• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钾与肾衰竭

Potassium and renal failure.

作者信息

Kunis C L, Charney A N

出版信息

Compr Ther. 1981 Mar;7(3):29-33.

PMID:7237977
Abstract

Hyperkalemia caused by decreased renal K+ secretion may be seen in patients with mild, moderate, or severe ARF or CRF. Decreased K+ secretion by the distal tubule may be due primarily to a decrease in tubular fluid flow rate, as in ARF, or it may be due to diminished circulating aldosterone concentrations, as in patients with hyporeninemic hypoaldosteronism. Patients with CRF adapt to K+ loads by increasing K+ excretion per nephron as well as by transferring K+ more rapidly into cells. However, an increased K+ load may still produce hyperkalemia in the CRF patient because of limitations in the adaptive responses. Hyperkalemia may present a true medical emergency in the patient with renal failure. Although the serum K+concentration can usually be controlled by the administration of calcium, glucose and insulin, sodium bicarbonate, diuretics, and/or the use of K+ exchange resins, dialysis may be necessary. Hyperkalemia complicating acute or chronic renal failure is an important, common problem requiring the use of peritoneal dialysis or hemodialysis.

摘要

肾钾分泌减少所致的高钾血症可见于轻度、中度或重度急性肾衰竭(ARF)或慢性肾衰竭(CRF)患者。远端肾小管钾分泌减少主要可能是由于肾小管液流速降低,如在急性肾衰竭时,或者可能是由于循环中醛固酮浓度降低,如在低肾素性低醛固酮血症患者中。慢性肾衰竭患者通过增加每个肾单位的钾排泄以及更快地将钾转运到细胞内来适应钾负荷。然而,由于适应性反应存在局限性,增加的钾负荷仍可能在慢性肾衰竭患者中导致高钾血症。高钾血症在肾衰竭患者中可能是真正的医疗急症。尽管血清钾浓度通常可通过给予钙剂、葡萄糖和胰岛素、碳酸氢钠、利尿剂和/或使用钾交换树脂来控制,但可能仍需要进行透析。并发急性或慢性肾衰竭的高钾血症是一个需要使用腹膜透析或血液透析的重要常见问题。

相似文献

1
Potassium and renal failure.钾与肾衰竭
Compr Ther. 1981 Mar;7(3):29-33.
2
[Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].[低肾素性低醛固酮血症与高钾血症的鉴别诊断]
Schweiz Med Wochenschr. 1982 Dec 4;112(49):1764-74.
3
[Hyperkalemias].[高钾血症]
Orv Hetil. 1999 Nov 21;140(47):2611-8.
4
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].[晚期慢性肾脏病中的电解质和酸碱平衡紊乱]
Nefrologia. 2008;28 Suppl 3:87-93.
5
Endocrine crises. Hyperkalemia.内分泌危象。高钾血症。
Crit Care Clin. 1991 Jan;7(1):155-74.
6
Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.(老年)慢性肾病患者同时进行肾素-血管紧张素-醛固酮阻断治疗在美国住院患者急性肾衰竭流行中起作用吗?——威斯康星州西北部肾病诊疗实践中遇到的三例严重急性肾衰竭病例
Hemodial Int. 2009 Oct;13 Suppl 1:S24-9. doi: 10.1111/j.1542-4758.2009.00416.x.
7
Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia.假设:一种用于区分持续性高钾血症患者低醛固酮血症和肾醛固酮抵抗的简单算法。
Nephrology (Carlton). 2008 Dec;13(6):459-64. doi: 10.1111/j.1440-1797.2008.00962.x. Epub 2008 Jun 1.
8
[Diagnosis and treatment of disorders of the potassium balance with special reference to infusion therapy].[钾平衡紊乱的诊断与治疗,特别涉及输注疗法]
Infusionsther Klin Ernahr. 1975 Dec;2(6):409-10,413-6.
9
[Hyperkalemia].[高钾血症]
Nouv Presse Med. 1974 May 25;3(21):1391-2.
10
Approach to hyperkalemic end-stage renal disease patients in the emergency department.急诊科高钾血症终末期肾病患者的处理方法。
Conn Med. 1999 Mar;63(3):131-6.

引用本文的文献

1
BRASH Syndrome Leading to Cardiac Arrest and Diffuse Anoxic Brain Injury: An Underdiagnosed Entity.导致心脏骤停和弥漫性缺氧性脑损伤的BRASH综合征:一种未被充分诊断的疾病。
Cureus. 2021 Oct 9;13(10):e18628. doi: 10.7759/cureus.18628. eCollection 2021 Oct.
2
Purification and Application of Genetically Encoded Potassium Ion Indicators for Quantification of Potassium Ion Concentrations within Biological Samples.用于定量生物样品中钾离子浓度的基因编码钾离子指示剂的纯化与应用
Curr Protoc Chem Biol. 2019 Sep;11(3):e71. doi: 10.1002/cpch.71.